Fixing our bodies with glass

Episode Summary

Executive Summary: This episode explores how glass is moving far beyond windows into healthcare, from bioactive glasses that stimulate bone repair and fight infection to nanostructured glass surfaces that deter bacteria and improve optics. It highlights both established medical uses and emerging technologies that could reshape wound care, implants, and hospital surfaces.

Main Topics: Bioglass for bone repair (Priority: 5/5): Julian Jones explains how bioglass dissolves in the body, releases ions, and bonds with bone to support regeneration rather than being rejected as an inert implant. History and mechanism of bioglass (Priority: 4/5): The origin story of Larry Hench’s invention and why glass composition makes it ideal for controlled ion release and osteogenesis. Clinical and consumer applications (Priority: 4/5): Bioglass is used in bone void filling, toothpastes, infection treatment, and new wound-care products, showing its range beyond orthopedics. Commercial and healthcare adoption barriers (Priority: 3/5): The conversation discusses why bioglass is not more widely used in the UK, including NHS purchasing and early commercialization missteps. Bounceable hybrid bioglass scaffolds (Priority: 5/5): Jones describes a new hybrid material combining bioactivity with mechanical resilience, aiming to address load-bearing bone defects and non-union fractures. Nanoparticle bioglass and therapeutic ion delivery (Priority: 4/5): Bioglass nanoparticles can deliver therapeutic ions such as strontium and zinc into cells at controlled rates, opening possibilities for targeted treatments. Nanostructured glass surfaces for anti-bacterial and optical functions (Priority: 5/5): Martina Mikalska presents a scalable lithography method for creating multifunctional glass surfaces that are anti-reflective, self-cleaning, and antibacterial.

Key Arguments: Bioglass works because it dissolves and releases naturally occurring ions that stimulate cells to form new bone and integrate the material with the body. Window glass would be rejected in the body, but bioglass is engineered to bond with tissue rather than be isolated by scar tissue. The glass network is useful because it can store ions and release them without unwanted chemical attachments, making biological effects more controllable. Changing composition and particle size can tune how fast bioglass dissolves and how long it acts in the body. Bioglass can be used in powder form for filling bone defects and in newer scaffold forms for more structural regeneration. A load-bearing hybrid bioglass could meet a major unmet need in non-union fractures by combining bone stimulation with cyclic mechanical support. Nanostructured glass surfaces may reduce infection risk without chemicals, making antimicrobial resistance less likely to emerge. The same glass nanostructures can also improve transparency, reduce glare, and prevent fouling or fogging, making them useful for hospitals and consumer products. Scaling and commercialization remain major challenges, but industrial partnerships suggest these technologies could move toward market adoption soon.

Data Points: Bioglass degradation time: about 1 year - Typical period over which the common bioglass powder used in bone defects dissolves and is replaced by new tissue Bone fracture healing time: about 6 weeks - Mentioned as a comparison; ordinary fractures typically heal faster than large defects treated with bioglass Nanostructure height: ~500 nanometers - Example height for nanocones or nanopillars on glass surfaces Nanostructure pitch: ~100 nanometers or less - Spacing scale used to achieve desired optical/surface properties Mask patterning time: 20 seconds - Time required to coat polymer micelles and generate the initial nanoscale pattern Bioglass nanoparticle size: 80 nanometers - Approximate size described for particles that can be taken up by cells and dissolve intracellularly Wound dressing cycle: 3 days - For the cotton-wool-like bioglass wound product, dressings are removed and replaced after three days as the material dissolves Cleaning cost timeframe: first 5 years - For tall buildings, cleaning glass windows can cost as much as installing them within the first five years Commercialization location: US, Finland, UK - Bioglass and related technologies are described as being more widely used or active in the US and Finland than in the UK

Pivotal Quotes: "You put glass into the body, and it speaks to your body and tells the bones what to do." — Julian Jones: Explaining the bioactive signaling role of bioglass in bone regeneration "The beauty of this is that you don't use any chemicals." — Martina Mikalska: Describing physically antimicrobial nanostructured glass surfaces "We now have this material that has the two properties: the stimulation of bone growth and the ability to take cyclic load." — Julian Jones: Introducing the new bouncy bioglass hybrid scaffold

Implications: Bioglass could expand from niche bone repair into broader regenerative medicine, infection control, and smart surfaces. If scalable and affordable, these glass technologies may reduce antibiotic reliance, improve wound healing, and make buildings and hospitals cleaner and safer.